{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:19:08Z","timestamp":1764260348887},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,17]]},"DOI":"10.7759\/cureus.60477","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:50:35Z","timestamp":1715935835000},"source":"Crossref","is-referenced-by-count":1,"title":["Immune-Mediated Necrotizing Myopathy Associated With Anti-signal Recognition Particle Antibody Complicated With Acute Respiratory Distress Syndrome: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Da-Wei","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00174-1","article-title":"Therapeutic management of immune-mediated necrotizing myositis","volume":"7","author":"Weeding E","year":"2021","unstructured":"Weeding E, Tiniakou E. Therapeutic management of immune-mediated necrotizing myositis. Curr Treatm Opt Rheumatol. 2021, 7:150-60. 10.1007\/s40674-021-00174-1","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.002","article-title":"Immune-mediated necrotising myopathy: A critical review of current concepts","volume":"49","author":"Day JA","year":"2019","unstructured":"Day JA, Limaye V. Immune-mediated necrotising myopathy: A critical review of current concepts. Semin Arthritis Rheum. 2019, 49:420-9. 10.1016\/j.semarthrit.2019.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg IE","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016, 280:39-51. 10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo YB","year":"2015","unstructured":"Luo YB, Mastaglia FL. Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochim Biophys Acta. 2015, 1852:622-32. 10.1016\/j.bbadis.2014.05.034","journal-title":"Biochim Biophys Acta"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe Y","year":"2016","unstructured":"Watanabe Y, Uruha A, Suzuki S, et al.. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry. 2016, 87:1038-44. 10.1136\/jnnp-2016-313166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99. 10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000335","article-title":"Spectrum of immune-mediated necrotizing myopathies and their treatments","volume":"28","author":"Pinal-Fernandez I","year":"2016","unstructured":"Pinal-Fernandez I, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol. 2016, 28:619-24. 10.1097\/BOR.0000000000000335","journal-title":"Curr Opin Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: Case series of 100 patients","volume":"10","author":"Suzuki S","year":"2015","unstructured":"Suzuki S, Nishikawa A, Kuwana M, et al.. Inflammatory myopathy with anti-signal recognition particle antibodies: Case series of 100 patients. Orphanet J Rare Dis. 2015, 10:61. 10.1186\/s13023-015-0277-y","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0303-17","article-title":"Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody","volume":"57","author":"Kusumoto T","year":"2018","unstructured":"Kusumoto T, Okamori S, Masuzawa K, et al.. Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody. Intern Med. 2018, 57:2045-9. 10.2169\/internalmedicine.0303-17","journal-title":"Intern Med"},{"key":"ref10","article-title":"Clinical and pathological characteristics of immune mediated necrotizing myopathy [Article in Chinese]","volume":"51","author":"Yang HX","year":"2019","unstructured":"Yang HX, Tian XL, Jiang W, et al.. Clinical and pathological characteristics of immune mediated necrotizing myopathy [Article in Chinese]. Beijing Da Xue Xue Bao Yi Xue Ban. 2019, 51:989-95.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series","volume":"62","author":"Valiyil R","year":"2010","unstructured":"Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series. Arthritis Care Res (Hoboken). 2010, 62:1328-34. 10.1002\/acr.20219","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez I","year":"2017","unstructured":"Pinal-Fernandez I, Parks C, Werner JL, et al.. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis Care Res (Hoboken). 2017, 69:263-70. 10.1002\/acr.22920","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet JB","year":"2006","unstructured":"Arlet JB, Dimitri D, Pagnoux C, et al.. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP). Neuromuscul Disord. 2006, 16:334-6. 10.1016\/j.nmd.2006.03.002","journal-title":"Neuromuscul Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2016.79.3.188","article-title":"Acute respiratory distress syndrome as the initial clinical manifestation of an antisynthetase syndrome","volume":"79","author":"Kim SH","year":"2016","unstructured":"Kim SH, Park IN. Acute respiratory distress syndrome as the initial clinical manifestation of an antisynthetase syndrome. Tuberc Respir Dis (Seoul). 2016, 79:188-92. 10.4046\/trd.2016.79.3.188","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"ref15","article-title":"An autoimmune storm: A case based literature review of successful management of lupus-polymyositis overlap syndrome complicated by multiple organ failure","volume":"15","author":"Ali AH","year":"2020","unstructured":"Ali AH, Kang M, Kaur K, Molokwu O, Al Adhami Saja KazaryanA, Yuvienco CR. An autoimmune storm: A case based literature review of successful management of lupus-polymyositis overlap syndrome complicated by multiple organ failure. Int J Clin Rheumatol. 2020, 15:","journal-title":"Int J Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-018-0110-6","article-title":"Myositis-related interstitial lung diseases: Diagnostic features, treatment, and complications","volume":"5","author":"Shappley C","year":"2019","unstructured":"Shappley C, Paik JJ, Saketkoo LA. Myositis-related interstitial lung diseases: Diagnostic features, treatment, and complications. Curr Treatm Opt Rheumatol. 2019, 5:56-83. 10.1007\/s40674-018-0110-6","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3766","article-title":"Anti-signal recognition particle necrotizing autoimmune myopathy: An atypical presentation","volume":"10","author":"Khan MH","year":"2018","unstructured":"Khan MH, Patel A, Pendharkar S. Anti-signal recognition particle necrotizing autoimmune myopathy: An atypical presentation. Cureus. 2018, 10:e3766. 10.7759\/cureus.3766","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3402\/ecrj.v2.27178","article-title":"Rituximab-induced interstitial lung disease: Five case reports","volume":"2","author":"Naqibullah M","year":"2015","unstructured":"Naqibullah M, Shaker SB, Bach KS, Bendstrup E. Rituximab-induced interstitial lung disease: Five case reports. Eur Clin Respir J. 2015, 2:10.3402\/ecrj.v2.27178","journal-title":"Eur Clin Respir J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/82.2.148","article-title":"Azathioprine-associated interstitial pneumonitis","volume":"82","author":"Bedrossian CW","year":"1984","unstructured":"Bedrossian CW, Sussman J, Conklin RH, Kahan B. Azathioprine-associated interstitial pneumonitis. Am J Clin Pathol. 1984, 82:148-54. 10.1093\/ajcp\/82.2.148","journal-title":"Am J Clin Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229877-immune-mediated-necrotizing-myopathy-associated-with-anti-signal-recognition-particle-antibody-complicated-with-acute-respiratory-distress-syndrome-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:50:38Z","timestamp":1715935838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229877-immune-mediated-necrotizing-myopathy-associated-with-anti-signal-recognition-particle-antibody-complicated-with-acute-respiratory-distress-syndrome-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.60477","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}